Other diseases of biliary tract

K11_BILIAOTH

biliary tract disease: A disease involving the biliary tree.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K83 Hospital discharge: ICD-9 — 576[2-9] Hospital discharge: ICD-8 — 576 Hospital discharge: excluded ICD-10 — K83.0 Hospital discharge: excluded ICD-8 — 57600\|57602\|57604 Cause of death: ICD-10 — K83 Cause of death: ICD-9 — 576[2-9] Cause of death: ICD-8 — 576 Cause of death: excluded ICD-10 — K83.0 Cause of death: excluded ICD-8 — 57600\|57602\|57604 2 out of 7 registries used, show all original rules.	3337
4. Check minimum number of events None	3337
5. Include endpoints None	3337
6. Filter based on genotype QC (FinnGen only)	3337

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K80-K87
Name in latin: Alii morbi ductuum biliarium

NAME	K11_BILIAOTH
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K83
HD_ICD_9	576[2-9]
HD_ICD_8	576
HD_ICD_10_EXCL	K830
HD_ICD_9_EXCL
HD_ICD_8_EXCL	57600\|57602\|57604
COD_MAINONLY
COD_ICD_10	K83
COD_ICD_9	576[2-9]
COD_ICD_8	576
COD_ICD_10_EXCL	K830
COD_ICD_9_EXCL
COD_ICD_8_EXCL	57600\|57602\|57604
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of biliary tract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27646	16678	10672
Only index persons	20800	12833	7967
Unadjusted period prevalence (%)
Whole population	0.41	0.48	0.30
Only index persons	0.41	0.47	0.30
Median age at first event (years)
Whole population	64.78	64.02	66.00
Only index persons	64.53	63.33	66.48

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3337	1860	1477
Unadjusted period prevalence (%)	0.64	0.63	0.65
Median age at first event (years)	62.77	59.49	66.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2938: Matched controls
29375

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

284.9

323.0

574

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

6163.5

323.0

522

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

60.1

323.0

414

K83.1

ICD-10 Finland

Obstruction of bile duct

4503599627370496.0

323.0

1682

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

603.7

323.0

698

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

344.7

323.0

559

K83.0

ICD-10 Finland

Cholangitis

+∞

323.0

649

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

372.4

323.0

519

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

361.5

323.0

580

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

84.8

323.0

404

UJK02

NOMESCO Finland

ERCP

469.4

323.0

1093

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

54.0

323.0

410

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1527.2

323.0

397

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

323.0

356

A09AA02

ATC

multienzymes (lipase, protease etc.)

95.3

323.0

431

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

250.3

323.0

599

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.8

323.0

769

932

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

+∞

284.0

268

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

23.2

276.6

408

203

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1447.9

275.2

264

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

2735.2

274.1

261

A05AA02

ATC

ursodeoxycholic acid; oral

48.8

273.6

334

57609

ICD-8 Finland

Other diseases of gallbladder and biliary, Alii definiti sive NUD

+∞

273.2

258

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

1280.7

245.2

236

130

Kela drug reimbursment

Malignant tumour

6.8

244.4

691

1275

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.3

236.0

712

1426

R10.1

ICD-10 Finland

Pain localized to upper abdomen

5.2

233.5

859

2177

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.8

230.9

1403

5719

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

39.7

223.0

284

JLC30

NOMESCO Finland

Pancreatoduodenectomy

299.4

219.5

221

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2095.9

215.1

206

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

229.4

208.4

213

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

21.1

200.0

303

159

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.8

195.5

750

1940

JN3AD

NOMESCO Finland

Abdominal CT examination

6.9

194.9

530

903

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

37.6

175.4

226

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

174.6

1259

5518

N02AA05

ATC

oxycodone; systemic

4.0

173.0

836

2661

JKA20

NOMESCO Finland

Cholecystectomy

50.5

170.7

207

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

+∞

160.9

153

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

546.4

158.4

156

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

15.5

154.6

262

184

K86.1

ICD-10 Finland

Other chronic pancreatitis

1603.4

154.5

149

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.7

151.5

376

550

Z51.5

ICD-10 Finland

Palliative care

5.7

146.4

460

924

A03FA01

ATC

metoclopramide; systemic, rectal

3.2

143.3

939

3722

UJK12

NOMESCO Finland

Peroral cholangioscopy

705.1

137.9

135

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

166.8

136.7

143

WX402

NOMESCO Finland

General anaesthesia

3.6

132.7

713

2408

WX302

NOMESCO Finland

Thoracal epidural anesthesy

6.5

132.2

368

629

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

72.1

132.1

151

57608

ICD-8 Finland

Other diseases of gallbladder and biliary, Dyskinesia viarum biliferarum

+∞

131.2

125

J01MA12

ATC

levofloxacin; systemic

3.2

129.9

850

3324

K85

ICD-10 Finland

Acute pancreatitis

175.3

128.5

134

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

157.1

128.4

135

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

72.9

127.9

146

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

123.8

118

K81.0

ICD-10 Finland

Acute cholecystitis

211.9

118.5

122

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.6

116.6

367

728

JN4CD

NOMESCO Finland

Very extensive body CT

6.8

115.0

307

492

A04AA02

ATC

granisetron; systemic, transdermal

5.2

115.0

390

843

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.3

113.5

288

429

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

+∞

109.0

104

R50.9

ICD-10 Finland

Fever, unspecified

3.4

109.0

626

2187

A02BC02

ATC

pantoprazole; systemic

2.5

108.6

2082

14600

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

108.0

851

3693

L01BC06

ATC

capecitabine; oral

6.8

103.8

278

446

N02AX02

ATC

tramadol; systemic, rectal

2.4

103.5

1458

8663

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

158.5

101.8

107

K83.4

ICD-10 Finland

Spasm of sphincter of Oddi

+∞

97.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

97.0

768

3304

H02AB02

ATC

dexamethasone; systemic

3.5

94.5

505

1653

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

21.6

93.9

140

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

92.6

530

1823

K80.8

ICD-10 Finland

Other cholelithiasis

58.9

91.7

108

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

+∞

91.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

87.7

1484

9340

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

8.4

86.2

198

251

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.8

85.3

257

478

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

12.6

83.4

153

127

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

33.2

82.7

109

UJF32

NOMESCO Finland

Coloscopy

2.3

82.0

950

4963

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

+∞

79.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.8

79.4

238

439

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

25.2

79.0

112

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

89.6

78.4

JN4BD

NOMESCO Finland

Extensive body CT

3.1

78.3

502

1853

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

53.3

77.8

Z94.4

ICD-10 Finland

Liver transplant status

75.7

77.6

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

392.4

77.2

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

76.4

WX002

NOMESCO Finland

Sedation and analgesia

2.4

75.6

764

3694

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.9

74.7

337

948

JN4AD

NOMESCO Finland

Body CT examination

3.6

74.6

366

1105

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

197.5

74.5

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

63.2

74.0

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

725.5

72.4

K83.3

ICD-10 Finland

Fistula of bile duct

+∞

72.2

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

100.1

71.2

JJC00

NOMESCO Finland

Allogenic transplantation of liver

187.0

70.4

K85.1

ICD-10 Finland

Biliary acute pancreatitis

+∞

69.0

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

69.0

R4190

NOMESCO Finland

Nutritional therapy

6.4

67.8

186

305

K86.3

ICD-10 Finland

Pseudocyst of pancreas

+∞

66.9

J01MA02

ATC

ciprofloxacin; systemic

2.0

66.7

1279

8151

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.2

66.6

271

692

K51.5

ICD-10 Finland

Left sided colitis

8.0

66.5

157

207

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

5.3

66.1

212

422

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

10.6

65.7

131

129

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

64.7

863

4710

K81.9

ICD-10 Finland

Cholecystitis, unspecified

217.9

62.3

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

+∞

61.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.9

61.0

178

316

ZXE00

NOMESCO Finland

One hour or less

2.0

60.9

1226

7871

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

5.1

60.9

203

422

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

58.8

1033

6271

JAH01

NOMESCO Finland

Laparoscopy

4.9

58.4

201

432

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

57.6

578

2734

WZC30

NOMESCO Finland

Teaching

2.6

57.2

478

2050

127

Kela drug reimbursment

Transplant complication

10.3

57.0

115

116

ZXD05

NOMESCO Finland

Urgent procedure

2.0

56.2

957

5714

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

558.2

55.8

B01AB05

ATC

enoxaparin; parenteral

2.0

55.5

981

5936

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.8

55.1

121

142

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

22.2

54.6

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

281.3

54.3

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

18.8

54.2

L04AX01

ATC

azathioprine; systemic

4.5

53.9

203

479

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

27.7

53.2

6663

FHL

Cholecystectomy and cholangiography

142.6

53.0

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

270.5

52.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

52.3

235

653

ZX120

NOMESCO Finland

Intravenous

2.7

51.4

378

1498

K86.8

ICD-10 Finland

Other specified diseases of pancreas

265.1

51.2

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

51.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.1

51.1

300

1026

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

137.4

50.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

50.2

404

1686

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

50.1

WVA20

NOMESCO Finland

Medicine administration

6.6

49.8

133

210

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

27.8

49.6

K76.9

ICD-10 Finland

Liver disease, unspecified

9.3

49.5

105

116

K83.5

ICD-10 Finland

Biliary cyst

+∞

48.0

A07EC02

ATC

mesalazine; oral, rectal

3.7

48.0

222

631

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

169.4

48.0

P01AB01

ATC

metronidazole; oral, rectal

1.8

47.8

1110

7312

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

5.1

47.5

157

323

TJK01

NOMESCO Finland

Laparoscopic cholangiography

475.1

47.4

A04AA01

ATC

ondansetron; systemic, rectal

3.2

47.4

272

911

A41.8

ICD-10 Finland

Other specified sepsis

7.6

47.2

114

156

R11

ICD-10 Finland

Nausea and vomiting

2.9

47.0

319

1200

A10AE04

ATC

insulin glargine; parenteral

2.7

46.1

344

1370

K83.2

ICD-10 Finland

Perforation of bile duct

+∞

45.9

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

24.6

45.9

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

45.7

207

578

B01AB10

ATC

tinzaparin; parenteral

3.0

45.5

279

980

JAH00

NOMESCO Finland

Laparotomy

5.2

45.4

147

295

C10AC01

ATC

colestyramine; oral

5.4

45.0

141

273

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

8.9

44.7

112

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

44.6

401

1771

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.4

44.3

138

265

L04AA06

ATC

mycophenolic acid; systemic

7.7

44.2

105

140

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

44.0

331

1324

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

43.1

1077

7197

6662

FHL

Cholecystectomy

116.8

42.8

JDE00

NOMESCO Finland

Gastrojejunostomy

31.7

42.4

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

13.3

41.9

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

41.3

495

2509

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.0

40.6

169

438

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

21.1

40.5

D76

ICPC

Malignant neoplasm pancreas

58.3

39.3

C24.02

ICD-10 Finland

Common bile duct

392.4

39.1

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

44.3

39.1

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

12.3

38.4

L04AD01

ATC

ciclosporin; systemic

6.9

38.2

147

TJK00

NOMESCO Finland

Intraoperative cholangiography

382.1

38.1

JJ5AT

NOMESCO Finland

197.4

37.9

A02BC05

ATC

esomeprazole; systemic

1.7

37.8

1150

8070

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

25.2

37.1

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

371.8

37.1

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

131.6

36.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.6

36.5

172

496

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

35.9

162

451

A06AH03

ATC

naloxegol; oral

7.9

35.4

106

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

29.8

35.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.2

34.2

194

644

K86.2

ICD-10 Finland

Cyst of pancreas

177.0

33.8

WW500

NOMESCO Finland

Blood transfusion

3.4

33.8

171

522

WX419

NOMESCO Finland

Other general anesthesy

9.4

33.5

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

+∞

33.4

J01DB01

ATC

cefalexin; oral

1.7

33.3

2242

19228

R10.0

ICD-10 Finland

Acute abdomen

4.5

32.8

120

275

WX004

NOMESCO Finland

Patient-controlled sedation

18.8

32.7

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

34.6

31.9

C24.09

ICD-10 Finland

Biliary duct or passage NOS

114.6

31.7

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

16.2

31.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

7.0

31.5

115

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.7

31.4

143

401

R4110

NOMESCO Finland

Physiotherapy

1.7

31.1

775

5063

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

30.7

1304

9831

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

22.3

30.4

D02

ICPC

Abdominal pain epigastric

3.0

30.3

184

639

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

30.2

N03AX16

ATC

pregabalin; oral

1.8

30.2

680

4297

A06AD11

ATC

lactulose; oral

1.9

30.0

518

2998

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.1

30.0

171

569

H02AB06

ATC

prednisolone; systemic

1.6

29.9

1307

9900

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

83.5

29.8

C24.00

ICD-10 Finland

Hepatic duct

107.8

29.7

K74.3

ICD-10 Finland

Primary biliary cirrhosis

12.9

29.3

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

29.2

A02BC01

ATC

omeprazole; systemic

1.7

29.1

818

5509

R18

ICD-10 Finland

Ascites

4.8

29.0

100

216

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

28.9

1087

7910

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

28.5

295

1384

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

8.9

28.4

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

28.1

152

488

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

27.8

317

1554

TK800

NOMESCO Finland

Hemodialysis

4.7

27.7

213

C03CA01

ATC

furosemide; systemic

1.6

27.5

954

6777

K51.8

ICD-10 Finland

Other ulcerative colitis

6.4

27.2

114

JKB00

NOMESCO Finland

Incision of bile duct

+∞

27.1

5768X

ICD-9 Finland

Other disorders of biliary tract, Other specified disorders of biliary tract

+∞

27.1

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

26.9

779

5269

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

7.0

26.8

K81.1

ICD-10 Finland

Chronic cholecystitis

273.4

26.8

N02BE01

ATC

paracetamol; systemic, rectal

1.7

26.7

2395

21302

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

37.0

26.1

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

26.1

JLA00

NOMESCO Finland

Exploration of pancreas

+∞

26.1

A07EA06

ATC

budesonide; oral, local oral

3.6

26.0

123

357

SPAT1255

SPAT

Intravenous administration of medicine

2.5

26.0

219

927

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

9.6

25.9

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

262.8

25.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.7

25.5

132

D98

ICPC

Cholecystitis/cholelithiasis

20.8

25.2

JKB20

NOMESCO Finland

Intraoperative cholangioscopy

+∞

25.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.4

24.8

141

SPAT1262

SPAT

Handing over of treatment supplies

1.8

24.7

524

3225

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

90.8

24.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

24.1

411

2351

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

7.5

24.1

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.8

24.1

176

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

24.0

57600

ICD-8 Finland

Other diseases of gallbladder and biliary, Cholesterosis vesicae felleae

+∞

24.0

5762A

ICD-9 Finland

Other disorders of biliary tract, Obstruction of bile duct

+∞

24.0

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

25.6

23.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

23.8

476

2870

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

241.8

23.7

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

9.5

23.5

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

33.6

23.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

23.1

703

4788

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

23.1

650

4337

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

23.0

491

3025

57500

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta

+∞

22.9

5765A

ICD-9 Finland

Other disorders of biliary tract, Spasm of sphincter of Oddi

+∞

22.9

K30

ICD-10 Finland

Functional dyspepsia

2.1

22.9

285

1446

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

22.9

312

1644

T90

ICPC

Diabetes non-insulin dependent

1.6

22.8

630

4180

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

231.6

22.6

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

22.6

499

3104

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

120.9

22.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

22.6

331

1791

5769X

ICD-9 Finland

Other disorders of biliary tract, Unspecified disorder of biliary tract

+∞

21.9

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

21.9

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

+∞

21.9

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

63.0

21.9

WX892

NOMESCO Finland

Monitored bed care

2.2

21.8

240

1156

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

221.5

21.6

K83

ICD-10 Finland

Other diseases of biliary tract

115.8

21.6

L03AA02

ATC

filgrastim; parenteral

3.3

21.5

113

356

I81

ICD-10 Finland

Portal vein thrombosis

17.5

21.3

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

21.2

670

4591

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

34.0

21.1

K50.8

ICD-10 Finland

Other Crohn disease

5.6

21.0

110

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

20.9

974

7301

57606

ICD-8 Finland

Other diseases of gallbladder and biliary, Stenosis viarum biliferarum

+∞

20.8

57607

ICD-8 Finland

Other diseases of gallbladder and biliary, Occlusio NUD viarum biliferarum

+∞

20.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

20.8

694

4817

D13

ICPC

Jaundice

77.3

20.7

N05CF01

ATC

zopiclone; oral

1.5

20.7

937

6979

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.1

20.2

195

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

6.4

20.2

JK3MB

NOMESCO Finland

Postoperative cholangiography

+∞

19.8

C03DA01

ATC

spironolactone; oral

1.8

19.7

343

1970

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

19.6

150

601

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

201.2

19.6

JK3RT

NOMESCO Finland

Percutaneous transhepatic removal of stones from bile ducts

201.2

19.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

19.3

381

2281

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

19.3

199

930

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.0

19.1

196

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.5

19.0

103

A02BC03

ATC

lansoprazole; oral

1.5

18.6

786

5737

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

100.6

18.6

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

12.3

18.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

18.4

465

2989

WX882

NOMESCO Finland

High dependency care

3.2

18.3

320

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.7

18.1

216

A02BA02

ATC

ranitidine; systemic

1.6

17.9

566

3856

A10AE05

ATC

insulin detemir; parenteral

2.3

17.9

162

712

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

17.8

377

2300

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

16.6

17.8

K92.1

ICD-10 Finland

Melaena

2.3

17.8

169

759

K75.0

ICD-10 Finland

Abscess of liver

18.1

17.8

57403

ICD-8 Finland

Cholelithiasis, Choledocholithiasis

+∞

17.7

57400

ICD-8 Finland

Cholelithiasis, Cum cholecystitide acuta

+∞

17.7

5741A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]

+∞

17.7

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

17.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

6.6

17.6

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.5

17.6

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

17.4

298

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

12.0

17.3

Z3226

NOMESCO Finland

Physiotherapist

1.6

17.1

495

3298

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

50.3

17.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

16.9

143

606

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

63.7

16.7

JKE15

NOMESCO Finland

Endoscopic lithotripsy in bile duct

+∞

16.7

Q44.21

ICD-10 Finland

Atresia of extrahepatic bile ducts

+∞

16.7

57601

ICD-8 Finland

Other diseases of gallbladder and biliary, Spasmus sphincteris Oddi (cum actasia viarum)

+∞

16.7

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

+∞

16.7

D01

ICPC

Abdominal pain/cramps general

1.9

16.5

257

1419

N03AX12

ATC

gabapentin; oral

1.7

16.5

393

2480

JL5BM

NOMESCO Finland

Bile and pancreas ducts MRI examination with 3 Tesla magnet

170.8

16.5

JL5CM

NOMESCO Finland

Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet

170.8

16.5

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

170.8

16.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

16.5

305

1785

JMA10

NOMESCO Finland

Transabdominal total splenectomy

8.3

16.5

JJA20

NOMESCO Finland

Open biopsy of liver

18.0

16.4

ZX121

NOMESCO Finland

Central venous catheter

13.4

16.4

H02AB04

ATC

methylprednisolone; systemic

1.7

16.3

391

2473

Z2446

NOMESCO Finland

Social worker

2.1

16.2

182

885

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.4

16.1

233

Z2221

NOMESCO Finland

Medical doctor

1.5

15.9

717

5276

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

10.1

15.9

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

15.8

170

807

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

15.8

499

3392

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

15.7

235

1280

K81.8

ICD-10 Finland

Other cholecystitis

+∞

15.6

5745A

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

15.6

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

+∞

15.6

UJD02

NOMESCO Finland

Gastroscopy

2.3

15.6

144

640

A04AA55

ATC

palonosetron, combinations; systemic

3.0

15.6

305

JK3AN

NOMESCO Finland

Biliary tract isotope imaging

160.7

15.5

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

16.1

15.2

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

8.7

15.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

15.2

759

5699

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.9

15.1

157

K65.0

ICD-10 Finland

Acute peritonitis

4.9

15.1

102

A03DA02

ATC

pitofenone and analgesics; systemic

3.3

15.0

225

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.4

15.0

125

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.9

14.9

159

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

8.9

14.9

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.6

14.8

111

442

K80

ICD-10 Finland

Cholelithiasis

9.2

14.7

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

14.6

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

+∞

14.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

14.5

166

815

L04AA01

ATC

[U] ciclosporin; systemic

4.1

14.5

139

K82.8

ICD-10 Finland

Other specified diseases of gallbladder

150.7

14.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

5.6

14.3

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

14.3

302

1839

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

14.3

208

1121

C25

ICD-10 Finland

Malignant neoplasm of pancreas

27.3

14.3

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.7

14.2

166

B01AB04

ATC

dalteparin; parenteral

2.1

14.2

157

758

WX110

NOMESCO Finland

Local anesthesy

1.4

14.2

1658

14360

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

14.2

262

1533

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

14.1

125

543

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.7

14.1

101

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

14.0

211

1152

Z94.0

ICD-10 Finland

Kidney transplant status

5.1

13.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

13.9

211

1156

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.1

13.8

245

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

13.8

120

516

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

13.7

310

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

13.7

110

455

57402

ICD-8 Finland

Cholelithiasis, Cum cholecystitide et choledocholithiasi

+∞

13.5

1282

FHL

ERCP and sphincterotomy

+∞

13.5

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

+∞

13.5

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

8.4

13.5

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.6

13.4

165

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

13.3

202

1106

Z3231

NOMESCO Finland

Registered nurse

1.4

13.3

714

5412

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

13.1

377

2498

SPAT1263

SPAT

Sampling

1.4

13.1

1073

8744

J01FF01

ATC

clindamycin; systemic

1.4

12.9

655

4904

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

22.6

12.9

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

12.9

195

1068

D97

ICPC

Liver disease NOS

7.7

12.9

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

12.8

100

409

SPAT1254

SPAT

Administration of medicine

1.6

12.8

406

2752

UJF92

NOMESCO Finland

Capsular endoscopy

3.4

12.8

182

TJA10

NOMESCO Finland

Laparocentesis

11.6

12.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

12.7

241

1420

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

12.7

104

435

A28

ICPC

Limited function/disability NOS

1.5

12.7

456

3181

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

70.1

12.6

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.4

12.5

103

431

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

12.5

130

610

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

12.5

155

784

UJK52

NOMESCO Finland

Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography

+∞

12.5

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.3

12.5

191

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

8.7

12.5

A04AD12

ATC

aprepitant; systemic

3.0

12.5

230

JK3PB

NOMESCO Finland

Peroperative cholangiography

130.5

12.4

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.3

12.4

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.9

12.4

259

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.7

12.4

E0000UV

ATC

1.4

12.4

964

7773

S18

ICPC

Laceration/cut

1.3

12.3

1071

8784

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

11.7

12.3

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

12.3

532

3856

N05BA04

ATC

oxazepam; oral

1.4

12.3

631

4733

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.7

12.1

XF612

NOMESCO Finland

Measurement of central venous pressure

11.1

12.0

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

10.1

12.0

57309

ICD-8 Finland

Other diseases of liver, Unspecified

13.4

11.9

J01MA14

ATC

moxifloxacin; systemic

1.7

11.9

228

1350

T89

ICPC

Diabetes insulin dependent

2.5

11.9

363

L04AA05

ATC

[U] tacrolimus; systemic

46.8

11.9

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.4

11.8

172

A11CC03

ATC

alfacalcidol; systemic

2.9

11.8

250

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.8

455

3222

K92.0

ICD-10 Finland

Haematemesis

2.8

11.7

284

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.8

11.7

262

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

11.7

973

7911

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

11.6

679

5205

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.1

11.6

208

PG1QT

NOMESCO Finland

Very extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

23.0

11.6

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

23.0

11.6

JKB21

NOMESCO Finland

Laparoscopic cholangioscopy

+∞

11.5

Q44.4

ICD-10 Finland

Choledochal cyst

+∞

11.5

57501

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis chronica

+∞

11.5

C24.01

ICD-10 Finland

Cystic duct

+∞

11.5

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

120.4

11.4

6664

FHL

Cholecystectomy and choledocotomy

120.4

11.4

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.7

11.4

D06

ICPC

Abdominal pain localized other

1.8

11.3

189

1067

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.8

11.3

121

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

11.8

11.3

SPAT1109

SPAT

Analgesia with portable analgesic pump

5.6

11.3

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

15.1

11.3

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

11.3

212

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.2

378

2593

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

9.6

11.2

ZY010

NOMESCO Finland

Hospital outpatient

2.2

11.2

109

499

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

11.1

167

914

H02AB09

ATC

hydrocortisone; systemic

3.0

10.9

215

D77

ICPC

Malignant digestive neopl other/NOS

7.4

10.9

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

10.9

J02AC01

ATC

fluconazole; systemic

1.3

10.9

892

7212

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

10.9

245

3AC01

NOMESCO Finland

4.4

10.9

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.1

10.9

195

A02BX02

ATC

sucralfate; oral

2.1

10.9

128

638

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.8

10.8

121

A41.4

ICD-10 Finland

Sepsis due to anaerobes

10.6

10.8

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

28.1

10.7

A10BA02

ATC

metformin; oral

1.4

10.7

700

5461

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

10.7

169

940

R53

ICD-10 Finland

Malaise and fatigue

1.4

10.6

525

3894

JF1BD

NOMESCO Finland

Very extensive small bowel CT

6.0

10.6

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.0

10.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

10.5

134

690

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

9.2

10.5

SPAT1301

SPAT

No procedures

1.3

10.5

823

6605

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

10.5

538

4019

JDA12

NOMESCO Finland

Endoscopic insertion of gastric stent

110.4

10.4

JKD50

NOMESCO Finland

Hepatoportoenterostomy

110.4

10.4

5745B

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,CUM OBSTR]

+∞

10.4

K82.2

ICD-10 Finland

Perforation of gallbladder

+∞

10.4

C08CA01

ATC

amlodipine; oral

1.3

10.4

976

8041

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

10.4

363

C07AB07

ATC

bisoprolol; oral

1.3

10.3

1295

11114

A03

ICPC

Fever

1.6

10.2

309

2068

J01DA01

ATC

[U] cefalexin; systemic

1.3

10.2

1575

13882

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

10.2

232

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

6.9

10.1

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

10.0

121

610

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

40.2

10.0

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

5.8

9.9

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

9.9

127

655

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.8

9.9

106

N06AX11

ATC

mirtazapine; oral

1.3

9.8

758

6053

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.3

9.8

143

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

9.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

9.8

104

498

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.8

746

5954

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

9.7

108

526

SPAT1153

SPAT

Removal of sutures

1.3

9.7

801

6468

A07AA02

ATC

nystatin; oral

1.8

9.5

163

933

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.1

9.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

9.5

194

1173

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

9.4

415

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

30.1

9.4

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

9.4

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

+∞

9.4

5750A

ICD-9 Finland

Other disorders of gallbladder, Acute cholecystitis

+∞

9.4

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

+∞

9.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

9.4

406

2933

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.3

9.3

143

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

9.3

335

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

9.3

133

K31.5

ICD-10 Finland

Obstruction of duodenum

10.7

9.3

UJF02

NOMESCO Finland

Peroral enteroscopy

4.9

9.3

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

9.2

395

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.7

9.2

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

9.2

172

1011

L01BB02

ATC

mercaptopurine; oral

4.8

9.1

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.8

9.1

L29.8

ICD-10 Finland

Other pruritus

3.8

9.1

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

36.8

9.0

L04AA10

ATC

sirolimus; oral

36.8

9.0

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.0

9.0

164

A07AA09

ATC

vancomycin; oral

3.3

9.0

131

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

9.0

919

7628

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

9.0

439

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

9.0

276

JN1DM

NOMESCO Finland

Upper part of abdomen very extensive MRI examination with 3 Tesla magnet

24.1

8.9

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.6

8.9

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

8.9

253

A07AA11

ATC

rifaximin; oral

12.6

8.9

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

12.6

8.9

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

12.6

8.9

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

8.8

424

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

8.8

112

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.7

618

4863

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

8.7

116

608

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

8.7

224

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

8.7

114

596

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.7

321

2243

JLC10

NOMESCO Finland

Distal pancreatectomy

14.1

8.7

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

14.1

8.7

A01

ICPC

Pain general/multiple sites

1.7

8.7

186

1138

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

50.1

8.7

D13.5

ICD-10 Finland

Benign neoplasm: Extrahepatic bile ducts

50.1

8.7

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

50.1

8.7

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

50.1

8.7

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

8.6

316

SPAT1269

SPAT

Other puncture and/or drainage

5.0

8.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.6

323

2269

C08CA05

ATC

nifedipine; systemic

1.7

8.6

177

1073

XX4BW

NOMESCO Finland

11.6

8.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

8.5

145

826

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

16.3

8.5

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

6.9

8.5

1XC07

NOMESCO Finland

9.0

8.5

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

10.0

8.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

8.5

126

690

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.4

601

4731

A10BH01

ATC

sitagliptin; oral

1.6

8.4

231

1510

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.4

8.4

306

E13.2

ICD-10 Finland

Other specified diabetes mellitus, with renal complications

90.3

8.4

JL5AM

NOMESCO Finland

Bile and pancreas ducts simple MRI examination with 3 Tesla magnet

90.3

8.4

JLA10

NOMESCO Finland

Biopsy of pancreas

90.3

8.4

XX4XT

NOMESCO Finland

Other canalization with radiological guidance

90.3

8.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

8.4

119

638

C07AA05

ATC

propranolol; systemic

1.4

8.4

419

3106

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

+∞

8.3

JKD00

NOMESCO Finland

Anastomosis of gallbladder to jejunum

+∞

8.3

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

8.3

JKW98

NOMESCO Finland

Other transluminal endoscopic operation on biliary tract

+∞

8.3

K82.4

ICD-10 Finland

Cholesterolosis of gallbladder

+∞

8.3

5761X

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS ALIA]

+∞

8.3

5756A

ICD-9 Finland

Other disorders of gallbladder, Cholesterolosis of gallbladder

+∞

8.3

57505

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholangitis alia sive NUD

+∞

8.3

PHC71

NOMESCO Finland

Suture of mesenteric or portal vein

+∞

8.3

AA1AD

NOMESCO Finland

CT of head and brain

1.3

8.3

609

4813

ZXA00

NOMESCO Finland

Right side

1.3

8.3

706

5699

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

8.5

8.3

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

8.3

130

725

H01CB02

ATC

octreotide; parenteral

9.5

8.3

A03FA02

ATC

cisapride; oral, rectal

1.6

8.2

206

1317

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

7.1

8.2

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

7.1

8.2

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

8.1

417

KA1FN

NOMESCO Finland

Isotope renography

4.7

8.1

A07EA02

ATC

hydrocortisone; rectal

2.6

8.1

225

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

11.7

8.1

J01XX08

ATC

linezolid; systemic

6.8

8.1

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

22.1

8.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

8.0

389

S97

ICPC

Chronic ulcer skin

1.8

8.0

142

824

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.0

7.9

RD210

NOMESCO Finland

3.0

7.9

140

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.8

7.9

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

4.5

7.9

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

7.8

156

936

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

7.8

242

1628

SPAT1216

SPAT

Assessment of functional ability

1.4

7.8

407

3042

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

7.8

300

2118

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

7.8

262

JX1XB

NOMESCO Finland

Other X-ray examination of alimentary tract with contrast

9.4

7.8

N06AA09

ATC

amitriptyline; systemic

1.5

7.7

244

1648

Q44.29

ICD-10 Finland

Atresia of bile ducts

45.1

7.7

XX9XB

NOMESCO Finland

Other X-ray examination with contrast

45.1

7.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

7.7

138

805

JAD10

NOMESCO Finland

Repair of incisional hernia

4.6

7.7

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.7

7.6

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

7.6

402

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

11.9

7.6

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

25.1

7.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

7.5

364

2683

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.5

209

1372

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

7.5

176

1107

B01AA03

ATC

warfarin; systemic

1.3

7.4

556

4399

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

7.4

137

802

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

7.4

398

2984

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.5

7.4

230

JKD30

NOMESCO Finland

Extrahepatic anastomosis of right or left hepatic duct to jejunum

80.3

7.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

7.4

152

920

K76.89

ICD-10 Finland

Other specified diseases of liver

7.7

7.4

1413

FHL

Laparoscopy and other therapeutic procedure

2.6

7.4

206

K29.1

ICD-10 Finland

Other acute gastritis

3.1

7.3

119

R51.80

ICD-10 Finland

Headache

1.5

7.3

289

2050

JKD40

NOMESCO Finland

Anastomosis of intrahepatic bile duct to jejunum

+∞

7.3

T86.4

ICD-10 Finland

Liver transplant failure and rejection

+∞

7.3

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

+∞

7.3

JKF96

NOMESCO Finland

Other secondary operation on biliary tract

+∞

7.3

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

+∞

7.3

JKB01

NOMESCO Finland

Laparoscopic incision of bile duct

+∞

7.3

JKB40

NOMESCO Finland

Suture of bile duct

+∞

7.3

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

+∞

7.3

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

7.3

136

803

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

10.9

7.3

RS220

NOMESCO Finland

3.0

7.2

126

PC4SC

NOMESCO Finland

Bowel angiography with X-ray

15.8

7.2

WX600

NOMESCO Finland

Single shot through catheter

3.1

7.1

116

8140/3-C24.9

ICD-O-3

Adenocarcinoma, NOS, of billiary tract, NOS

30.1

7.1

E86

ICD-10 Finland

Volume depletion

2.2

7.1

301

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

5.0

7.1

WX872

NOMESCO Finland

Intensive care

1.8

7.1

116

658

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

7.1

399

3021

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

7.0

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

10.0

7.0

191

Kela drug reimbursment

Erlotinib

10.0

7.0

N02AC04

ATC

dextropropoxyphene; oral

1.8

7.0

110

615

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

7.0

176

1128

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.7

7.0

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.2

6.9

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.2

6.9

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.7

6.9

170

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

5.8

6.9

K74.0

ICD-10 Finland

Hepatic fibrosis

13.8

6.9

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.2

6.9

103

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

6.9

444

3436

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.9

221

1501

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.5

6.9

214

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

6.9

105

583

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.9

388

2936

R52.2

ICD-10 Finland

Other chronic pain

2.1

6.8

352

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

6.8

197

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.7

6.8

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

40.1

6.8

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

40.1

6.8

JLC50

NOMESCO Finland

Atypical pancreatectomy

40.1

6.8

M54.5

ICD-10 Finland

Low back pain

1.3

6.7

701

5795

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

16.7

6.7

A12AA04

ATC

calcium carbonate; oral

2.7

6.7

167

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

6.7

139

845

N17.8

ICD-10 Finland

Other acute renal failure

3.2

6.7

105

M01AX17

ATC

nimesulide; oral

1.3

6.7

607

4932

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

22.5

6.7

J01CA04

ATC

amoxicillin; systemic

1.2

6.6

1979

18367

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

6.6

156

984

H02AB07

ATC

prednisone; oral

1.4

6.6

342

2548

J01EA01

ATC

trimethoprim; systemic

1.3

6.6

621

5064

Y0599

ICD-8 Finland

Investigation of digestive system

2.5

6.6

205

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.6

252

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.6

397

3033

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

7.8

6.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.9

6.6

133

L03AA13

ATC

pegfilgrastim; parenteral

1.9

6.6

519

ZXE90

NOMESCO Finland

More than 22 hours

3.3

6.5

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

10.0

6.5

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.8

6.5

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

6.5

258

ZX100

NOMESCO Finland

Oral

2.7

6.5

158

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.5

1573

14275

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

6.4

121

718

N18.8

ICD-10 Finland

Other chronic renal failure

2.1

6.4

329

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.4

277

2001

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

6.4

536

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.4

6.4

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.4

6.4

WX610

NOMESCO Finland

Patient controlled analgesia

4.7

6.4

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

14.3

6.4

M48.0

ICD-10 Finland

Spinal stenosis

1.4

6.4

294

2151

E87.6

ICD-10 Finland

Hypokalaemia

2.0

6.4

408

ZX108

NOMESCO Finland

Inhalation

3.6

6.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

6.4

225

1563

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.2

6.3

K72.1

ICD-10 Finland

Chronic hepatic failure

9.3

6.3

K75.4

ICD-10 Finland

Autoimmune hepatitis

9.3

6.3

5AB14

NOMESCO Finland

9.3

6.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

6.3

146

919

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

18.0

6.3

R06AE07

ATC

cetirizine; oral

1.2

6.3

962

8312

57404

ICD-8 Finland

+∞

6.2

6653

FHL

Cholecocotomy or hepaticotomy and choledocoscopy (includes stone removal)

+∞

6.2

57405

ICD-8 Finland

Cholelithiasis, Choledocholithiasis suspecta

+∞

6.2

K91.5

ICD-10 Finland

Postcholecystectomy syndrome

+∞

6.2

JLB96

NOMESCO Finland

Other incision, drainage or dilatation of pancreas

+∞

6.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.2

620

5087

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

6.2

166

1080

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

6.2

190

1275

J01CA08

ATC

pivmecillinam; oral

1.2

6.2

921

7925

A10AB06

ATC

insulin glulisine; parenteral

3.4

6.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.2

913

7848

N06AX21

ATC

duloxetine; oral

1.5

6.2

216

1495

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

6.2

310

2301

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

6.1

254

G04CA02

ATC

tamsulosin; oral

1.3

6.1

531

4283

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

7.7

6.1

D99

ICPC

Disease digestive system other

3.2

6.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

12.5

6.1

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

8.6

6.0

176

Kela drug reimbursment

Regorafenib

10.0

6.0

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

10.0

6.0

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1782

7764

3.78

312.18

9.6

3.0

u/l

59.1

35.0

15.10

1718

7323

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

587

187

37.88

307.65

1.8

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2098

7741

5.61

307.65

6.9

2.1

u/l

62.5

56.5

1.88

1995

7044

(3024980) IgG subclass 4 [Mass/volume] in Serum

369

272

15.13

307.65

3.0

1.5

g/l

1.0

0.9

0.48

286

213

(3007566) Smooth muscle Ab [Titer] in Serum

456

551

9.43

307.65

1.9

1.1

titre

112.8

86.7

0.39

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

891

864

13.70

307.65

5.8

2.8

u/ml

1384.8

2620.4

0.40

830

721

(3000570) Elastase.pancreatic [Mass/mass] in Stool

556

596

10.99

307.65

1.6

1.3

ug/g

164.3

299.7

27.61

315

336

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

944

2184

5.63

307.65

8.5

1.8

u/l

99.7

33.1

1.15

875

1839

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1184

2386

7.14

307.65

5.4

1.9

g/l

0.2

13.75

1130

2188

(3034770) Mitochondria Ab [Titer] in Serum

455

553

9.37

307.65

1.9

1.1

titre

205.0

984.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1257

2545

7.32

307.65

9.9

2.3

umol/l

31.8

7.9

36.22

1183

2179

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2588

13622

5.01

307.65

22.7

5.7

umol/l

23.2

11.5

37.15

2518

12855

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1405

2812

7.90

307.65

5.9

3.9

ug/l

24.5

25.6

0.05

1255

2291

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

652

465

17.18

307.65

6.2

3.0

u/ml

719.5

1025.5

0.22

626

426

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

390

276

15.87

307.65

3.6

2.4

u/ml

209.9

77.3

0.29

390

265

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

235

134

18.79

292.10

2.3

1.0

titre

—

(3032080) INR in Blood by Coagulation assay

2193

11290

3.75

289.52

14.8

9.5

inr

1.2

1.3

5.06

666

3079

(3024561) Albumin [Mass/volume] in Serum or Plasma

2232

11988

3.60

267.44

13.1

4.5

g/l

32.6

35.1

66.48

2139

11021

(3023368) Bacteria identified in Blood by Culture

1691

7667

3.44

267.37

8.1

4.1

—

(40768441) Liver Pathology biopsy report

216

151

15.22

241.50

2.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1465

6679

3.13

218.98

12.3

3.7

84.0

87.7

6.67

1440

6496

(3005719) IgG [Mass/volume] in Serum or Plasma

646

1761

4.31

214.25

3.0

2.8

g/l

10.9

10.5

1.52

584

1606

(3023183) Ammonium ion [Moles/volume] in Plasma

325

502

7.06

203.60

5.1

2.5

umol/l

40.0

36.2

0.81

276

417

(3044640) Blood type and Crossmatch panel - Blood

1651

8372

2.92

198.66

4.3

2.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

546

1398

4.47

195.63

2.3

1.9

g/l

1.3

1.4

0.97

507

1257

(3014576) Chloride [Moles/volume] in Serum or Plasma

897

3423

3.22

176.47

10.7

6.6

mmol/l

104.2

0.04

878

3349

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1048

4428

2.99

171.92

5.2

3.2

mmol/l

0.8

9.81

999

4089

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2021

12159

2.68

163.04

6.6

4.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

176

167

11.07

162.57

1.7

1.2

titre

76.3

115.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

176

167

11.07

162.57

1.7

1.2

titre

281.7

118.0

1.48

(3042936) Bacteria identified in Isolate by Culture

918

3713

3.03

161.56

2.8

2.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2421

15999

2.87

160.85

10.2

4.5

mmol/l

7.1

6.7

10.83

2354

14952

(3020779) Urea [Moles/volume] in Serum or Plasma

680

2420

3.27

147.90

12.2

6.6

mmol/l

9.2

10.3

3.47

661

2286

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

595

2002

3.40

141.34

2.0

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

203

281

7.63

139.69

1.2

1.1

g/l

1.6

1.5

2.81

192

251

(3027135) IgG subclass 1 [Mass/volume] in Serum

162

171

9.91

138.60

2.1

1.3

g/l

7.2

6.8

0.37

127

(3028192) IgG subclass 2 [Mass/volume] in Serum

161

171

9.84

137.11

2.1

1.3

g/l

3.3

2.9

0.92

126

(3024139) IgG subclass 3 [Mass/volume] in Serum

161

171

9.84

137.11

2.1

1.3

g/l

0.5

0.4

0.24

128

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2329

15799

2.57

134.09

9.7

2.9

u/l

187.2

47.3

89.12

2226

14400

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1253

6441

2.51

133.62

4.1

2.3

—

(4062490)

159

173

9.60

132.97

2.1

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2760

20568

2.98

127.58

25.5

7.0

u/l

156.7

77.9

120.08

2683

19190

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

854

3735

2.73

126.03

2.9

2.5

21.3

22.0

0.64

766

3148

(3022948) Iron [Moles/volume] in Serum or Plasma

937

4325

2.62

123.79

2.9

2.4

umol/l

11.6

12.6

3.61

884

3986

(3017143) Hepatitis C virus Ab [Presence] in Serum

600

2197

3.11

122.65

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2237

15220

2.43

122.53

18.2

8.8

e9/l

4.3

4.1

3.43

2005

13175

(3002582) Erythrocytes [#/volume] in Urine

1452

8299

2.33

118.59

4.4

3.2

e6/l

37.2

85.9

2.80

1189

6338

(3004789) Transferrin [Mass/volume] in Serum or Plasma

878

4000

2.62

118.47

2.9

2.4

g/l

2.3

0.49

826

3690

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2102

14172

2.31

113.67

10.6

6.6

mmol/l

1.2

12.71

1746

11878

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

106

13.32

111.24

4.8

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1959

12900

2.26

111.14

10.2

5.8

mmol/l

1.2

11.27

1848

11552

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

632

2518

2.86

110.12

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

110

11.08

110.03

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

789

3537

2.61

108.98

8.0

5.4

mmol/l

1.0

0.73

755

3254

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

229

460

5.27

108.35

7.8

5.0

iu/ml

977.2

543.3

0.54

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

114

106

11.10

106.47

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

114

106

11.10

106.47

1.1

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

13.22

103.52

47.0

31.3

ug/l

7.2

7.4

0.17

(3026782) Osmolality of Urine

1039

5404

2.34

102.81

3.6

2.8

mosm/kgh2o

530.0

543.4

1.10

930

4564

(3018677) aPTT in Platelet poor plasma by Coagulation assay

883

4328

2.41

99.60

3.2

2.1

30.8

29.9

4.12

863

4188

(3018095) Leukocytes [#/volume] in Urine

1554

9631

2.15

98.72

5.1

3.7

e6/l

71.4

119.1

1.83

1251

6806

(3016650) Hepatitis A virus Ab [Presence] in Serum

180

318

5.93

97.78

1.1

1.0

—

(3042733) HLA Ab [Presence] in Serum

16.34

97.76

2.1

5.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1312

7640

2.18

97.55

4.3

3.2

e6/l

0.5

0.21

1064

5760

(3000991) Gas panel - Venous blood

576

2340

2.77

95.71

11.4

7.9

—

(3000850) Epithelial cells [#/volume] in Urine

1066

5766

2.25

94.72

3.6

2.6

e6/l

6.5

5.5

1.21

969

5031

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

922

4702

2.33

94.24

2.1

1.8

—

(42870588) Differential panel, method unspecified - Blood

1473

9079

2.11

93.44

8.3

5.7

—

(36304419) Bacteria [Presence] in Urine

1268

7407

2.15

92.34

4.3

3.1

—

(40768797) Stomach Pathology biopsy report

747

3508

2.46

91.75

1.5

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

447

1630

3.01

90.43

1.7

1.5

—

(4035726)

578

2433

2.66

89.11

1.6

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

174

330

5.51

87.56

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

184

373

5.16

85.94

7.8

5.9

mg/l

12.4

11.9

0.48

172

350

(3037522) Nuclear Ab [Titer] in Serum

675

3132

2.45

84.42

1.9

1.3

titre

518.6

514.8

0.02

172

677

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

255

679

3.98

84.40

6.7

4.4

mg/l

1.7

1.5

2.17

243

614

(3018418) pH of Serum or Plasma

1372

8475

2.05

84.10

6.2

3.8

7.4

0.13

358

1540

(3014111) Lactate [Moles/volume] in Serum or Plasma

571

2454

2.60

84.03

9.3

6.8

mmol/l

1.4

0.65

556

2347

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

180

370

5.08

82.71

1.6

1.3

u/ml

343.0

278.3

1.40

132

222

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

439

1674

2.87

81.48

10.6

7.8

mmol/l

24.6

25.0

1.50

432

1659

(3006315) Basophils [#/volume] in Blood

1875

13063

1.99

80.48

8.5

5.7

e9/l

0.0

2.74

1636

11117

(3019069) Monocytes/100 leukocytes in Blood

1791

12286

1.99

80.35

9.1

6.2

8.5

8.8

2.99

1698

11418

(3031040) Bacteria [#/volume] in Urine by Automated count

2356

17825

2.09

79.82

6.3

4.7

e6/l

1402.6

2918.5

0.88

248

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

184

399

4.82

79.36

1.6

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

1779

12224

1.98

78.88

8.8

5.9

2.6

2.9

5.16

1688

11331

(3007164) IgA [Mass/volume] in Serum or Plasma

845

4437

2.21

78.48

2.0

1.5

g/l

2.7

2.5

1.73

637

2534

(3002030) Lymphocytes/100 leukocytes in Blood

1814

12567

1.97

78.31

9.0

6.0

24.7

27.2

15.22

1711

11623

(3010375) cycloSPORINE [Mass/volume] in Blood

9.82

78.26

33.5

26.2

ug/l

141.9

120.4

1.59

(3001604) Monocytes [#/volume] in Blood

1859

13000

1.97

77.93

8.5

5.7

e9/l

0.6

0.13

1628

11044

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

334

1120

3.20

77.62

2.2

1.9

ug/l

2.2

2.5

0.16

308

965

(3013115) Eosinophils [#/volume] in Blood

1906

13494

1.96

76.46

8.9

5.9

e9/l

0.2

1.43

1684

11665

(3002032) Base excess in Venous blood by calculation

587

2667

2.46

76.22

6.2

3.7

mmol/l

1.5

2.0

2.49

496

2135

(3022096) Basophils/100 leukocytes in Blood

1734

11901

1.95

76.15

8.9

6.0

0.6

0.7

2.97

1645

11037

(3019198) Lymphocytes [#/volume] in Blood

1889

13353

1.96

75.89

8.7

5.7

e9/l

1.8

1.9

1.88

1669

11573

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

172

367

4.89

75.60

1.6

1.4

u/ml

118.6

112.7

0.41

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

170

363

4.88

74.65

4.1

2.7

u/ml

1054.5

2017.1

0.35

(3048689) Calprotectin [Mass/mass] in Stool

583

2670

2.43

74.23

3.6

2.2

ug/g

170.4

144.2

0.97

499

2072

(3021447) Carbon dioxide [Partial pressure] in Venous blood

583

2675

2.43

73.90

6.2

3.7

kpa

5.7

5.8

3.65

570

2587

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

181

413

4.58

73.30

1.7

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

107

150

7.34

72.51

5.0

1.9

umol/l

39.5

7.6

3.59

(3018010) Neutrophils/100 leukocytes in Blood

1763

12387

1.90

69.83

8.7

5.8

59.9

57.7

10.51

1671

11520

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

255

772

3.49

69.68

2.2

1.7

—

(3002256) Pathology report gross observation

656

3263

2.26

68.53

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

564

2654

2.35

67.03

11.0

7.5

g/l

114.7

120.7

8.93

550

2552

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

232

684

3.57

65.96

2.2

1.4

iu/ml

17.3

17.0

—

(3016502) Oxygen saturation in Arterial blood

596

2890

2.29

65.96

10.8

7.3

96.0

95.4

1.17

583

2775

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

203

554

3.84

64.66

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

642

3304

2.17

60.96

2.0

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

789

4395

2.04

60.70

3.6

3.0

e6/l

3.1

2.4

0.82

471

2398

(3048929) Epstein Barr virus Ab [Presence] in Serum

201

570

3.69

60.51

1.6

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1417

9586

1.83

60.38

6.0

3.3

mmol/l

2.3

2.4

12.43

1314

8212

(3003396) Base excess in Arterial blood by calculation

633

3252

2.17

60.31

10.5

6.9

mmol/l

0.4

1.1

4.11

522

2530

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

639

3314

2.15

59.34

2.0

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

236

752

3.30

59.31

3.8

2.5

82.6

90.4

3.37

228

709

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

344

1359

2.71

58.90

6.5

4.2

mmol/l

23.9

24.2

1.07

317

1226

(3024932) HLA-DR beta [Type]

10.50

58.87

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

255

858

3.13

58.53

2.2

1.5

titre

403.3

381.1

—

(3024471) HLA-A [Type]

10.34

58.23

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

629

3269

2.14

57.97

10.5

6.8

kpa

12.9

12.2

2.76

615

3097

(40758558) Short blood count panel - Blood

1072

6715

1.88

57.91

13.0

6.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1524

10638

1.80

57.70

4.8

3.8

ng/l

34.1

92.5

0.81

1200

7738

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

573

2876

2.20

57.68

5.2

3.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

628

3271

2.13

57.50

10.6

6.9

kpa

5.0

5.1

0.92

615

3100

(3009445) Proteinase 3 Ab [Units/volume] in Serum

297

1101

2.86

57.37

2.0

1.5

u/ml

4.4

20.4

1.34

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

820

4729

1.97

56.66

3.4

2.8

e6/l

1.1

1.2

0.37

503

2715

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1119

7152

1.85

56.39

3.0

2.2

mg/l

3.3

3.0

2.74

1006

6035

(3017315) Amylase [Enzymatic activity/volume] in Urine

101

7.78

55.26

1.3

1.2

u/l

252.9

226.3

0.10

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

154

390

4.09

54.36

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

120

251

4.92

53.92

1.3

1.2

u/l

59.1

58.4

0.04

102

170

(3024354) Oxygen [Partial pressure] in Venous blood

468

2225

2.28

53.49

5.4

3.3

kpa

4.7

4.6

0.44

452

2140

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

103

190

5.56

53.31

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

212

678

3.27

52.88

3.9

2.7

218.6

194.7

2.91

203

644

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

104

196

5.44

52.59

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

338

1422

2.53

50.67

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

242

860

2.96

50.36

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2288

18366

1.78

50.13

5.8

4.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

267

1004

2.80

50.06

3.5

2.9

u/ml

0.3

0.44

152

572

(3021589) Normoblasts [#/volume] in Blood

1590

11548

1.72

49.89

20.7

9.7

e9/l

0.0

0.26

1336

9354

(3036489) Thrombin time

250

932

2.82

47.60

3.4

2.2

22.8

21.6

2.13

227

834

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

149

5.90

47.55

3.4

1.4

g/l

0.9

1.0

1.52

149

(3022145) Colonoscopy Study observation

532

2782

2.09

47.45

1.9

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1031

6726

1.77

46.70

1.5

1.3

—

(3026008) Bacteria identified in Urine by Culture

1272

8807

1.72

46.59

3.6

3.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

593

3253

2.00

46.26

4.0

4.1

u/l

270.3

251.3

0.63

563

3059

(40768804) Tissue Pathology biopsy report

1468

10597

1.69

45.81

2.7

2.1

—

(3017181) Myelocytes/100 leukocytes in Blood

440

2170

2.18

45.57

4.4

4.0

1.0

0.9

0.29

199

624

(3027315) Oxygen [Partial pressure] in Blood

188

613

3.19

45.35

5.7

4.4

kpa

8.9

8.4

2.64

183

598

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1480

10729

1.68

45.28

3.7

2.7

ug/l

185.7

136.6

5.14

1384

9765

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

870

5442

1.81

45.19

6.2

3.0

mmol/l

2.5

8.70

788

4760

(3012501) Base excess in Blood by calculation

187

610

3.19

45.08

5.7

4.4

mmol/l

2.6

2.8

0.47

138

432

(3013290) Carbon dioxide [Partial pressure] in Blood

187

611

3.18

44.95

5.7

4.4

kpa

5.0

0.88

182

597

(3023487) Leukocytes [#/volume] in Peritoneal fluid

7.53

44.12

1.9

2.3

e6/l

7637.2

869.1

0.57

(40760892) CBC W Ordered Manual Differential panel - Blood

852

5355

1.79

43.26

5.8

4.4

—

(3025941) Bacteria identified in Stool by Culture

304

1320

2.43

42.35

1.5

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

5.97

42.11

1.5

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

330

1496

2.34

41.71

12.8

9.0

mmol/l

23.9

24.4

1.93

318

1378

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1500

11070

1.64

41.68

3.2

2.2

nmol/l

75.1

79.2

6.88

1376

9732

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

450

2328

2.08

40.91

6.0

3.6

mmol/l

1.2

4.77

421

2000

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

461

2418

2.05

40.35

2.3

1.7

1.6

1.5

1.49

385

2090

(3022217) INR in Platelet poor plasma by Coagulation assay

669

3983

1.85

40.23

22.6

27.3

inr

1.3

1.4

0.75

107

519

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

130

362

3.70

40.12

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

408

2067

2.11

39.13

4.5

4.0

0.2

0.1

0.86

183

575

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

365

1771

2.19

39.10

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1677

12863

1.61

38.85

6.4

5.1

estimate

0.0

0.50

420

2325

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

142

5.45

38.81

1.4

1.2

u/l

40.0

18.8

1.28

118

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

328

1528

2.27

38.80

14.4

9.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.71

38.76

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

172

4.98

38.70

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

7.38

38.58

1.9

2.1

e6/l

11447.6

31009.4

0.37

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.56

38.24

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

126

355

3.65

38.22

2.0

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1691

13029

1.60

38.19

4.9

3.9

estimate

0.0

0.80

406

2276

(3035350) Ketones [Presence] in Urine by Test strip

1668

12830

1.60

37.79

4.9

3.8

estimate

0.0

0.00

417

2294

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

153

495

3.19

37.36

4.2

3.6

60.7

57.6

1.79

153

495

(40761536) Microorganisms panel - Urine sediment

415

2157

2.06

37.06

5.4

4.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

389

1980

2.09

36.74

4.3

3.8

0.7

0.6

0.51

135

448

(3010421) pH of Blood

192

716

2.78

36.42

5.8

4.2

7.4

0.24

182

596

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

287

1303

2.32

36.00

4.1

2.7

0.7

0.6

1.59

279

1245

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

208

4.42

35.82

1.3

nmol/l

1.2

1.5

1.15

185

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

8.90

35.44

2.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

536

3086

1.88

35.42

1.9

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

525

3021

1.88

34.70

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

340

1723

2.08

32.33

4.9

3.3

g/l

119.9

127.3

7.52

331

1681

(3044007) Cell count panel - Peritoneal fluid

6.99

32.22

2.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

561

3368

1.80

32.13

3.2

2.4

2.1

1.8

4.18

519

2949

(3033799) Differential panel - Peritoneal fluid

6.66

31.46

2.2

2.1

—

(3020891) Body temperature

251

1148

2.28

30.86

6.9

4.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

134

453

3.04

30.37

1.5

nmol/l

0.7

0.8

0.99

111

374

(1616796) Gas panel - Central venous blood

159

592

2.77

30.24

4.7

3.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

817

5541

1.63

29.58

4.2

3.8

ng/l

222.6

565.5

1.14

687

4601

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1294

9755

1.53

29.57

5.2

4.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

944

6639

1.59

29.35

4.6

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

816

5544

1.62

29.29

2.4

1.7

mg/l

2.2

1.4

3.16

667

4240

(3030981) Hyaline casts [#/volume] in Urine by Automated count

283

1395

2.12

28.86

3.1

2.7

e6/l

0.5

0.3

1.00

274

1357

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1168

8648

1.54

28.80

3.0

3.1

ng/l

1628.3

1620.5

0.02

1021

7440

(3025159) Blasts/100 leukocytes in Blood

361

1946

1.96

28.77

4.8

4.0

0.0

0.5

1.04

149

487

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

17.81

28.15

4.5

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2289

19623

1.53

27.28

5.9

4.1

mm/h

17.5

13.3

22.94

2127

18004

(3029937) Albumin [Presence] in Urine by Test strip

967

6948

1.55

26.94

5.3

4.3

estimate

0.0

1.08

397

2222

(3036481) Cortisol [Moles/volume] in Serum or Plasma

404

2324

1.84

26.29

2.4

2.2

nmol/l

376.0

372.1

0.12

380

2118

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

162

4.26

26.08

2.0

1.5

u/l

4.2

5.9

0.44

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

267

1351

2.06

25.34

1.8

1.7

g/l

1.5

0.64

226

1148

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2871

26142

1.70

24.55

39.8

14.8

mg/l

29.8

24.9

14.82

2699

20730

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

739

5094

1.58

24.33

1.3

u/ml

1.2

1.7

0.94

203

1271

(3004809) Band form neutrophils/100 leukocytes in Blood

120

438

2.80

23.72

3.0

3.5

1.5

0.04

325

(3021960) Folate [Moles/volume] in Serum or Plasma

930

6794

1.51

23.36

1.8

1.6

nmol/l

20.2

20.8

0.51

831

5756

(3013512) EKG study

1075

8101

1.48

23.14

4.7

4.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

844

6054

1.53

23.06

2.0

1.7

pmol/l

8297409.6

24878089.0

0.92

687

4904

(3019060) Gas panel - Arterial blood

334

1886

1.86

22.94

6.9

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

318

1784

1.86

22.28

10.7

6.4

mmol/l

23.8

24.7

3.46

303

1658

(3026493) Urate [Moles/volume] in Serum or Plasma

943

6975

1.49

22.06

3.5

2.7

umol/l

3686.6

5780.2

0.83

817

5950

(3000494) Fungus identified in Specimen by Culture

475

3001

1.68

22.06

1.9

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

142

589

2.47

21.74

3.3

2.5

14.4

16.1

3.76

294

(3023520) Reticulocytes [#/volume] in Blood

418

2561

1.72

21.74

3.0

2.5

e9/l

76.5

68.1

2.82

317

1912

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

126

495

2.61

21.60

1.5

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

154

675

2.34

20.88

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

150

651

2.37

20.80

1.8

1.6

—

(3009343) pH of Capillary blood

303

1724

1.83

20.25

5.2

4.0

7.4

0.01

207

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

107

401

2.72

20.15

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

305

1742

1.83

20.13

5.3

4.0

kpa

5.0

5.2

2.63

275

1604

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.66

19.91

1.2

1.5

g/l

9.2

14.9

3.69

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

358

2154

1.74

19.79

3.3

2.8

ml/min/173m2

61.0

62.0

0.16

156

905

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

4.29

19.47

2.4

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

1665

1.80

18.23

5.4

4.0

mmol/l

1.6

1.9

0.43

201

1236

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

220

1170

1.94

18.09

2.2

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

259

3.02

17.71

2.7

2.8

—

(3044889) 12 lead EKG panel

2153

18899

1.39

17.70

4.8

4.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

172

849

2.08

17.43

6.1

3.7

mmol/l

3.8

3.9

0.37

155

801

(3051651) Icteric interference index of Serum or Plasma

157

3.61

17.24

5.1

3.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

204

1077

1.95

17.14

2.1

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

294

2.83

16.84

2.9

4.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.47

16.11

3.6

2.2

u/ml

1067.0

81109.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

345

2169

1.66

16.10

4.8

3.7

ng/l

102.5

89.7

1.50

299

1826

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

12.36

16.03

5.0

3.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.39

15.88

1.2

1.4

g/l

20.2

28.2

1.79

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

124

3.83

15.81

1.3

1.1

u/l

102.9

87.1

0.49

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

143

3.61

15.72

1.2

mmol/l

11.3

12.6

0.52

(3019309) Folate [Moles/volume] in Red Blood Cells

760

5698

1.43

15.69

2.0

1.8

nmol/l

1298.9

1172.3

2.85

592

4200

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

345

2.59

15.24

1.1

iu/ml

23.1

110.6

1.10

(3024928) Oxygen saturation in Venous blood

125

578

2.21

15.00

4.6

3.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

139

671

2.12

14.96

4.0

3.2

mmol/l

24.2

25.0

0.99

119

582

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

125

3.72

14.86

1.3

1.1

u/l

25.6

32.7

0.43

(3028626) Oxygen [Partial pressure] in Capillary blood

136

653

2.13

14.84

7.2

3.9

kpa

8.6

8.1

2.19

121

613

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

107

3.96

14.84

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

386

2551

1.58

14.65

2.3

ug/l

4.6

7.2

3.73

328

2195

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1406

11766

1.34

14.46

2.3

2.0

pmol/l

91.3

95.3

2.29

812

5860

(3003327) Ova and parasites identified in Stool by Light microscopy

148

742

2.04

14.41

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

818

6303

1.39

14.24

4.4

3.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

133

644

2.11

14.22

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

133

644

2.11

14.22

1.6

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

329

2.53

13.58

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.28

13.36

1.5

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

361

2421

1.55

12.80

2.3

2.5

g/l

64.4

66.2

3.82

332

2173

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

8.13

12.75

1.3

1.2

ml/s/173m2

1.6

1.1

0.86

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

235

2.71

12.10

1.6

—

(3019977) pH of Arterial blood

130

3.34

11.89

3.3

2.9

7.4

0.41

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.68

11.87

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2901

27384

1.45

11.70

41.7

17.5

mmol/l

138.7

139.6

56.42

2859

26607

(3033705) Calcium.ionized [Moles/volume] in Venous blood

360

2.34

11.66

3.5

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

380

2.30

11.58

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

3.10

11.54

2.6

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

1023

8382

1.32

11.48

3.5

3.1

mmol/l

6.9

7.2

1.10

838

6998

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

139

3.19

11.36

1.1

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2903

27447

1.44

11.21

41.8

17.7

mmol/l

4.0

7.45

2860

26630

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

115

579

2.02

11.14

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

141

3.15

11.10

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

112

560

2.03

11.06

1.6

1.3

mmol/l

58.6

63.4

0.56

449

(3002385) Erythrocyte distribution width [Ratio]

2325

21266

1.31

11.01

44.6

18.3

14.5

13.8

60.24

2299

20730

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1036

8547

1.31

10.95

2.3

2.1

u/l

179.5

219.2

0.94

958

7973

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

761

1.88

10.85

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1029

8500

1.30

10.73

4.4

3.9

mg/mmol

12.6

8.8

0.95

654

5277

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

197

1191

1.69

10.66

7.8

4.9

1.7

1.6

0.35

185

1115

(3022313) Gas panel - Capillary blood

205

1257

1.67

10.52

5.7

4.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

769

1.86

10.51

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

194

1174

1.69

10.46

7.8

5.0

0.9

1.02

181

1102

(3037121) Protein [Mass/volume] in Urine

170

993

1.75

10.41

4.0

3.3

g/l

0.3

0.17

394

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

479

2.08

10.31

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

123

652

1.92

10.30

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

775

1.84

10.26

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

146

820

1.82

10.21

4.6

3.5

—

(3011648) Oxygen content in Venous blood

228

2.57

10.11

4.9

4.0

11.0

11.2

0.14

228

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2618

24465

1.33

9.84

34.9

14.2

ml/min/173m2

78.6

76.5

4.92

2338

20124

(4281824)

293

2.35

9.75

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

116

619

1.91

9.55

3.1

2.2

g/l

118.5

128.1

3.22

436

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

127

698

1.85

9.55

2.0

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.81

9.49

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1599

14120

1.25

9.29

3.0

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

119

647

1.87

9.26

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.05

9.23

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.42

9.07

1.0

—

(3017732) Neutrophils [#/volume] in Blood

259

1742

1.53

9.04

3.3

3.1

e9/l

4.3

4.2

0.25

192

1302

(3021901) Oxygen saturation in Capillary blood

486

1.98

8.87

3.9

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

420

2.05

8.74

1.7

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.39

8.52

2.4

1.9

65.6

55.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.54

8.49

4.5

4.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

237

2.39

8.41

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

237

2.39

8.41

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

237

2.39

8.41

1.5

—

(3019150) Specific gravity of Urine by Refractometry

705

5692

1.30

8.39

5.3

4.4

kg/l

1.0

0.10

107

861

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

102

546

1.90

8.36

1.7

—

(3012516) Albumin [Mass/volume] in Urine

962

8086

1.27

8.31

3.5

3.1

mg/l

322.3

318.7

0.01

627

5041

(3051611) Lipemic interference index of Serum or Plasma

302

2.21

8.28

5.3

3.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

123

2.95

8.22

1.3

nmol/l

1.1

1.2

0.10

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

370

2.08

8.16

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

337

2.13

8.14

1.5

1.4

—

(3016750) Collection duration of Urine

146

2.76

8.12

2.4

2.1

min

504.9

490.1

0.34

102

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2903

27747

1.36

7.86

29.0

10.3

u/l

38.2

24.9

69.32

2847

26535

(3043410) Blood group antigens tested for on Red Blood Cells

3.59

7.84

3.2

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

132

2.82

7.84

3.0

2.4

—

(3004775) Volume in Urine collected for unspecified duration

203

2.43

7.74

2.4

2.2

772.9

623.3

1.72

123

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

292

2.18

7.69

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

127

747

1.73

7.67

4.9

4.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

332

2.10

7.66

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

273

2.22

7.66

1.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

327

2.10

7.57

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

327

2.10

7.57

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

201

1335

1.54

7.46

4.2

3.8

u/ml

107.9

63.7

0.73

192

1288

(3005988) Vibrio sp identified in Specimen by Organism specific culture

329

2.09

7.45

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

316

2.11

7.43

6.3

5.4

mmol/l

7.2

7.3

0.12

263

(3015171) Extractable nuclear Ab [Units/volume] in Serum

147

912

1.64

7.29

1.3

1.2

u/ml

0.3

1.5

1.62

(3024522) Salmonella sp identified in Specimen by Organism specific culture

335

2.05

7.12

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

171

1111

1.57

7.02

6.2

4.4

mmol/l

24.4

24.9

1.37

161

1018

(3004451) EKG impression Narrative

135

2.68

6.98

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

2.96

6.95

1.3

2.6

umol/l

36.8

156.6

—

(3020393) Adenovirus Ag [Presence] in Stool

4.38

6.95

1.6

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

183

2.42

6.92

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

279

2.13

6.89

3.7

3.4

56.7

58.1

0.15

168

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

138

857

1.64

6.84

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.27

6.74

2.6

1.7

—

(40761511) CBC panel - Blood by Automated count

2819

26948

1.30

6.71

33.6

14.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

463

1.86

6.68

4.5

2.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

168

2.46

6.67

1.5

2.0

e6/l

504.4

670.2

0.76

(3019225) pH of Specimen

377

2874

1.35

6.63

5.3

4.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

417

1.89

6.50

1.5

g/l

30.2

31.5

0.39

377

(3000330) Specific gravity of Urine by Test strip

210

1451

1.48

6.49

4.4

3.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

178

2.38

6.37

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.84

6.25

1.4

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

107

638

1.70

6.22

2.9

2.4

ug/min

103.0

93.1

0.08

382

(44790049)

319

1.99

6.17

1.9

1.5

—

(44790048)

319

1.99

6.17

1.9

1.5

—

(44806118)

319

1.99

6.17

1.9

1.5

—

(44790047)

319

1.99

6.17

1.9

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

117

2.66

5.98

1.2

ratio

1.1

1.0

0.52

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

159

2.41

5.95

1.5

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

115

708

1.65

5.94

3.1

3.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

203

2.23

5.94

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.20

5.86

4.1

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.20

5.86

4.1

2.5

—

(3014271) Vancomycin [Susceptibility]

173

2.33

5.83

3.3

2.8

—

(3011412) CD3 cells [#/volume] in Blood

225

2.15

5.78

1.8

2.3

e9/l

0.9

1.1

0.52

135

(3004716) Salmonella sp identified in Stool by Organism specific culture

165

1114

1.51

5.74

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

107

1697

0.62

5.68

1.5

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

2.37

5.63

1.5

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

202

2.19

5.59

1.3

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

183

2.26

5.57

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

143

944

1.54

5.54

3.0

3.2

mg/l

30.9

63.4

1.54

102

770

(40768446) Kidney Pathology biopsy report

2.85

5.50

2.1

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

143

946

1.53

5.49

3.0

3.2

mg/l

291.0

117.4

0.31

101

770

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

139

915

1.54

5.46

3.0

3.2

ratio

1.2

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

225

2.10

5.39

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

395

1.81

5.30

2.2

2.8

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

+∞

5.21

1.4

0.0

umol/l

161.8

—

(3047181) Lactate [Moles/volume] in Blood

133

878

1.54

5.17

9.9

5.8

mmol/l

1.3

0.42

114

779

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

414

1.78

5.12

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

596

1.65

5.10

4.0

3.5

mg/l

32.3

27.4

0.81

366

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

341

2664

1.31

5.08

3.0

2.9

ng/l

252.9

227.1

0.42

322

2428

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

13.36

5.08

5.1

2.3

mg/l

3.0

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

144

976

1.50

4.96

2.6

2.3

ug/l

512.3

681.5

0.30

136

916

(40761535) Cells panel - Urine sediment

307

2373

1.32

4.94

4.0

3.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

131

2.38

4.81

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

131

2.38

4.81

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.08

4.78

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

113

734

1.56

4.75

2.3

1.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.95

4.71

3.2

2.6

—

25.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1116

0.58

4.60

1.3

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

297

1.87

4.56

1.8

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

104

2.51

4.54

2.0

2.1

u/ml

2402.3

1129.0

0.51

104

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

312

1.84

4.53

1.3

1.4

pmol/l

243.6

274.7

0.31

246

(21494755) Public health laboratory ask at order entry panel

101

1538

0.65

4.53

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

423

1.72

4.52

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

322

1.82

4.42

1.4

1.5

—

(3016038) Potassium [Moles/volume] in Urine

196

2.05

4.38

1.5

1.2

mmol/l

30.0

34.1

0.69

170

(3004588) Protein electrophoresis panel - Serum or Plasma

264

2033

1.32

4.38

2.3

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.72

4.36

1.6

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

190

2.06

4.34

1.9

2.3

42.8

47.1

—

(3011985) Renin [Units/volume] in Plasma

339

1.78

4.32

1.4

mu/l

61.3

48.3

0.40

293

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

120

2.34

4.24

1.3

1.5

56.9

68.5

0.76

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

138

964

1.45

4.14

2.3

2.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

167

2.11

4.12

1.9

2.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

347

1.74

4.02

1.9

2.1

u/l

1674.1

3980.3

0.61

138

(3012441) Differential panel - Pleural fluid

318

1.77

3.99

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

267

1.85

3.99

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.43

3.96

6.7

4.7

mg/l

69.2

75.8

0.17

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

204

1.97

3.96

1.9

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

637

1.54

3.95

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

131

2.22

3.92

1.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

131

2.22

3.92

1.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

131

2.22

3.92

1.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

131

2.22

3.92

1.2

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

457

1.63

3.90

1.1

1.3

miu/ml

223.6

213.6

0.07

190

(3023199) Leukocytes [#/volume] in Pleural fluid

373

1.70

3.89

1.4

e6/l

4527.7

2316.3

0.43

270

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.64

3.89

1.2

ug/l

349.6

453.1

0.08

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.64

3.89

1.9

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

219

1672

1.33

3.88

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

3.85

1.2

1.3

63.3

80.7

0.89

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

159

2.09

3.82

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

159

2.09

3.82

1.5

2.4

e6/l

402.1

508.6

0.62

135

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.01

3.81

1.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.74

3.75

1.1

—

(3037756) Immunofixation for Serum or Plasma

597

1.54

3.74

1.3

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

181

2.00

3.73

2.3

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

238

1.86

3.69

1.1

—

(44806420)

2.43

3.63

2.0

2.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.43

3.63

1.0

85.3

89.3

0.21

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

108

742

1.47

3.58

1.9

1.5

iu/ml

0.3

9.2

0.65

168

(3039000) Anion gap in Blood

637

1.51

3.55

12.1

6.5

mmol/l

11.2

0.02

569

(3018572) Chloride [Moles/volume] in Blood

637

1.51

3.55

12.1

6.5

mmol/l

105.5

105.0

0.56

569

(3026389) Candida sp identified in Specimen by Organism specific culture

353

1.68

3.54

1.3

—

(3022621) pH of Urine by Test strip

229

1786

1.30

3.52

3.8

3.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

426

5043

0.82

3.51

2.9

3.1

ug/l

0.7

0.8

1.26

288

3433

(3017569) Oxygen content in Arterial blood

125

2.17

3.47

2.3

2.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

613

7007

0.85

3.41

4.3

4.4

21.7

21.9

0.12

298

3540

(3002619) Bacteria identified in Specimen by Culture

2.99

3.41

1.2

1.1

—

(3035880) pH of Pleural fluid

167

1.99

3.38

1.2

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

101

2.29

3.35

1.8

2.5

190.2

156.1

1.05

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.71

3.35

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.72

3.34

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.62

3.30

1.2

1.1

71.1

88.2

1.14

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

751

0.58

3.27

1.5

1.6

mg/l

9.0

3.3

0.64

531

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

148

1095

1.37

3.27

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.79

3.25

2.1

2.0

mg/l

8.3

9.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

286

1.72

3.24

1.5

1.8

—

3.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

156

2.00

3.24

2.6

2.7

umol/l

136.4

34.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

163

1.97

3.23

1.8

1.3

promille

1.0

1.2

0.28

125

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.44

3.21

1.7

2.6

230.5

167.8

1.08

(1002224) Polysomnography panel

857

0.61

3.19

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.86

3.19

1.2

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.25

3.12

2.7

2.6

—

(36660697) Celiac disease serology panel - Serum

232

1849

1.27

3.05

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.46

3.04

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

339

1.63

3.00

1.5

1.4

e6/l

22124.7

82724.2

1.57

198

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

187

1454

1.30

2.98

3.1

3.2

pmol/l

4.2

4.4

2.37

165

1271

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

10.01

2.98

1.6

umol/l

1460.0

4096.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.83

2.91

1.2

mmol/l

1.4

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.51

2.87

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

1.62

2.85

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2415

23262

1.14

2.82

36.5

16.4

36.4

39.1

28.46

1617

15554

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.45

2.79

1.4

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.23

2.77

1.0

1.5

pmol/l

28.3

43.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

173

1.86

2.76

1.9

2.4

14.6

12.4

0.26

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.86

2.75

1.1

68.0

83.9

—

(3022475) Manganese [Moles/volume] in Blood

5.01

2.72

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.37

2.72

1.4

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

248

1.70

2.72

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

218

1.75

2.72

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.29

2.67

1.3

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.13

2.64

1.2

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.13

2.64

1.2

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

192

1525

1.27

2.63

2.3

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.46

2.54

2.7

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.43

2.53

1.7

1.5

—

(3045788) Cell count panel - Pleural fluid

300

1.61

2.53

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

172

1358

1.28

2.49

1.3

u/ml

420.6

200.3

0.71

158

1235

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

232

1.69

2.48

2.3

2.0

u/field

2.7

2.0

0.39

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.38

2.47

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

102

2.07

2.47

1.2

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

166

1.81

2.44

1.4

1.6

—

72.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.55

2.44

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

311

1.58

2.44

1.2

1.1

118.6

115.4

0.17

277

(3028433) Virus identified in Specimen by Culture

2.12

2.38

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

494

1.45

2.32

1.4

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

586

1.41

2.32

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

148

1.83

2.28

2.9

4.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.37

2.12

1.5

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

197

1.68

2.12

1.5

u/l

14.8

13.7

0.43

187

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.14

2.08

1.3

1.1

miu/ml

1193.7

1592.8

1.57

(4268621)

229

1.62

2.08

2.3

—

(3000492) Spirometry study

264

2233

1.20

2.07

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

249

0.44

2.07

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

191

1.68

2.06

2.4

2.6

mmol/l

7.4

6.9

0.55

124

(3039443) Prostate specific Ag panel - Serum or Plasma

444

0.58

2.06

1.5

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

254

1.58

2.03

1.3

1.1

—

2.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

645

1.36

2.02

1.8

mg/l

10.1

11.8

1.00

594

(3052592) Norovirus Ag [Presence] in Stool

2.23

2.00

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

1049

1.28

2.00

1.8

u/l

43.8

38.9

2.12

122

909

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

605

1.36

1.97

1.1

u/ml

5.3

8.5

0.35

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

464

4125

1.14

1.96

1.3

iu/ml

43.1

36.2

0.39

157

1306

(21494814) CD8 cells/100 lymphocytes in Specimen

1.98

1.95

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

103

789

1.32

1.93

2.4

g/l

0.0

0.00

724

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.75

1.93

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

104

800

1.31

1.90

2.4

g/l

0.0

0.00

725

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

111

864

1.29

1.87

2.5

2.4

g/l

0.0

1.33

785

(3017509) Phencyclidine [Presence] in Urine

4.17

1.82

1.8

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.27

1.80

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

382

3375

1.15

1.78

1.4

—

(3008295) Osmolality of Serum or Plasma

296

1.49

1.77

1.3

1.4

mosm/kgh2o

279.1

275.6

0.36

218

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2058

19864

1.09

1.77

4.3

4.0

pmol/l

15.0

14.9

0.79

1856

17757

(3034426) Prothrombin time (PT)

2.03

1.74

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

464

1.39

1.74

1.3

1.2

u/ml

55.8

37.0

0.39

(3045683) HLA typing for celiac disease panel - Blood or Tissue

118

1.78

1.70

1.0

—

(3049717) Cytology report of Urine Cyto stain

132

1065

1.25

1.69

2.3

2.7

—

(3045142) Bone marrow Pathology biopsy report

316

1.46

1.68

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.19

1.67

1.2

mmol/l

1.9

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

3.16

1.66

1.2

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.03

1.64

1.4

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.57

1.61

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

362

1.42

1.59

1.8

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1074

1.24

1.58

2.2

2.4

g/l

10.3

0.05

111

898

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

338

1.43

1.56

1.4

1.2

u/ml

5.6

3.3

0.34

112

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.43

1.53

1.0

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.34

1.52

1.0

—

(3003338) MCHC [Mass/volume]

2218

21549

1.09

1.51

45.3

19.6

g/l

330.3

331.7

11.09

2198

21339

(3044009) aPTT.lupus sensitive (LA screen)

2.86

1.50

1.3

1.1

—

(3019174) dRVVT (LA screen)

2.86

1.50

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

573

1.32

1.50

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.86

1.50

1.1

1.6

pmol/l

13.1

15.4

0.99

(3010813) Leukocytes [#/volume] in Blood

2929

28841

1.13

1.49

52.9

22.0

e9/l

7.1

6.8

6.85

2863

27826

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2490

24320

1.09

1.48

7.5

5.9

mmol/mol

41.9

40.1

13.02

2287

22189

(4306422)

317

1.43

1.48

1.2

—

(3007461) Platelets [#/volume] in Blood

2927

28822

1.13

1.48

52.9

21.9

e9/l

249.0

247.6

0.48

2864

27911

(3006270) Folate [Moles/volume] in Blood

243

1.49

1.47

1.1

nmol/l

333.4

353.7

0.22

206

(3006462) Nitrate [Presence] in Urine

124

1.70

1.47

3.0

3.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

121

986

1.24

1.46

2.7

2.4

g/l

0.5

1.0

1.53

100

840

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

1.65

1.44

2.6

2.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.13

1.44

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.73

1.43

1.2

1.0

—

(3024731) MCV [Entitic volume]

2927

28831

1.12

1.43

52.7

21.9

91.3

91.4

0.26

2890

28270

(3035941) MCH [Entitic mass]

2927

28832

1.12

1.43

52.7

21.8

30.2

30.4

6.13

2890

28269

(3026361) Erythrocytes [#/volume] in Blood

2927

28834

1.12

1.42

52.9

21.9

e12/l

4.2

4.4

89.21

2857

27820

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

433

3921

1.12

1.40

1.3

1.2

u/ml

12.1

13.2

0.11

162

1450

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.25

1.40

1.1

1.3

65.2

75.6

—

(44806071)

2.61

1.36

1.2

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.94

1.36

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

223

1.48

1.36

3.4

2.9

mg/l

32.1

30.5

0.05

170

(3000963) Hemoglobin [Mass/volume] in Blood

2926

28841

1.12

1.33

53.4

22.1

g/l

125.4

133.8

139.18

2888

28285

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.64

1.33

1.7

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

305

3418

0.88

1.33

4.3

4.7

32.7

33.2

0.30

214

2198

(4198724)

2.04

1.32

2.4

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

143

1696

0.84

1.31

2.5

2.4

au/ml

26.3

24.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

250

1.44

1.30

2.3

1.4

20.5

27.9

0.77

153

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.50

1.30

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.89

1.28

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

881

0.78

1.27

2.1

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.72

1.27

1.1

u/ml

0.6

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

311

1.39

1.26

3.8

3.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.00

1.23

1.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

322

1.37

1.21

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

365

1.35

1.21

1.9

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

576

1.27

1.20

1.7

1.8

iu/l

3.8

5.1

1.15

183

(1761868) Lipid panel - Serum or Plasma

759

8076

0.92

1.20

3.4

3.0

—

(3000012) Reticulocyte production index

148

1.56

1.20

1.3

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

222

1.45

1.18

1.5

u/ml

15.2

21.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

110

911

1.21

1.18

2.4

2.3

g/l

36.9

37.3

0.31

764

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

157

1.53

1.17

3.2

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

157

1.53

1.17

3.2

1.7

—

(4211845)

133

1.58

1.17

3.0

3.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

1.15

1.4

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.67

1.10

1.1

u/ml

0.5

0.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

168

1457

1.16

1.09

1.2

iu/ml

123.2

155.0

0.40

530

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.38

1.09

2.0

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

1152

1.18

1.07

2.3

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

512

0.74

1.07

1.4

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

1153

1.18

1.07

2.3

2.4

g/l

3.7

3.8

0.19

100

815

(3024869) Neuronal Ab [Presence] in Serum

1.93

1.06

1.3

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

1154

1.18

1.06

2.3

2.4

g/l

7.3

7.4

0.40

103

853

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.12

1.05

3.6

15.6

mmol/l

3.7

5.4

—

(4015189)

1.79

1.04

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.06

1.02

1.0

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

179

1.46

1.02

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

1.46

1.02

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

1.46

1.02

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

1075

1.18

1.02

2.3

2.4

g/l

3.2

3.1

0.22

103

833

(3028707) Methadone [Presence] in Urine by Screen method

205

1.42

1.00

2.3

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.77

1.00

1.4

1.5

ug/l

11.5

9.3

0.76

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.00

1.00

1.7

2.3

—

(40768795) Lymph node Pathology biopsy report

265

1.36

0.99

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1.44

0.98

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1.44

0.98

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1.44

0.98

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.95

0.97

1.7

2.0

umol/l

13.8

19.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.80

0.96

3.9

6.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

345

1.31

0.96

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.96

0.0

1.0

—

3.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

668

1.22

0.95

1.3

1.2

u/ml

10.7

47.3

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.95

0.0

1.0

—

-4.6

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.95

0.0

1.0

—

7.4

—

(3006598) pH of Arterial cord blood

0.00

0.95

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.94

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.62

0.93

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

277

1.34

0.93

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

277

1.34

0.93

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.22

0.93

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

331

1.30

0.90

1.3

1.2

u/ml

5.3

4.5

0.14

147

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

1.53

0.90

1.0

—

(3045716) Anion gap in Serum or Plasma

135

1.48

0.89

3.8

2.5

mmol/l

13.4

9.5

1.12

106

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

832

8727

0.94

0.89

4.5

5.1

ug/l

2.5

3.6

1.38

730

7782

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

119

1.52

0.88

1.2

—

(40768443) Skin Pathology biopsy report

133

1157

1.16

0.87

1.2

—

(40768800) Prostate Pathology biopsy report

550

0.78

0.87

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

139

1214

1.15

0.87

2.4

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

370

1.27

0.85

1.3

nmol/l

0.1

0.4

—

(40768793) Breast Pathology biopsy report

658

0.80

0.85

1.2

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

230

1.35

0.84

2.1

1.8

—

0.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.94

0.84

1.2

1.1

umol/24h

1.3

1.7

—

(3014891) Appearance of Pleural fluid

1.78

0.84

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

121

1388

0.87

0.82

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

627

1.20

0.80

1.3

1.2

u/ml

2.7

8.0

1.51

103

(3047007) Chlamydophila sp Ab [Presence] in Serum

303

1.29

0.79

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.79

0.0

1.5

—

0.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.28

0.79

1.2

1.3

nmol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

621

1.20

0.77

1.3

1.2

u/ml

2.1

3.4

—

(3001729) Color of Synovial fluid

0.00

0.76

0.0

1.5

—

(4010399)

210

1903

1.11

0.76

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.57

0.74

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.84

0.73

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

653

1.18

0.73

1.3

1.4

iu/l

38.1

31.1

0.84

539

(3011288) Drugs identified in Urine by Screen method

308

1.27

0.72

2.4

2.3

—

(3026480) Teichoate Ab [Titer] in Serum

1.92

0.70

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

110

1.46

0.68

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

144

1.39

0.67

6.4

6.3

—

(4027681)

119

0.59

0.67

1.4

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.63

0.66

2.0

1.5

ng/l

128.1

128.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.63

0.66

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

214

0.70

0.66

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

241

1.29

0.65

1.6

1.7

—

(3017704) Immunofixation for Urine

154

1.37

0.65

1.1

1.5

—

(3036603) Volume of Urine

180

1.34

0.65

1.3

1.4

1880.3

1687.6

0.50

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

141

1568

0.89

0.63

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

314

1.24

0.63

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.63

0.62

4.1

3.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

173

1.33

0.61

1.5

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.67

0.61

15.0

11.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

315

3367

0.93

0.61

1.5

1.4

—

(4133840)

1.60

0.61

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

122

1.40

0.60

2.5

1.3

0.5

4.2

1.47

(3027456) Digoxin [Moles/volume] in Serum or Plasma

695

1.15

0.60

3.6

3.1

nmol/l

0.9

0.8

0.70

527

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

210

1.29

0.58

4.8

4.9

u/ml

73.8

58.7

0.08

(3014051) Protein [Presence] in Urine by Test strip

650

1.16

0.58

2.6

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.58

0.0

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.51

0.58

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

539

0.83

0.57

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.48

0.57

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

319

1.23

0.57

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

275

0.76

0.57

1.3

mmol/l

8.3

7.4

0.45

195

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.56

2.0

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2498

25268

0.95

0.56

4.8

4.5

mmol/l

1.4

1.5

9.49

2244

22870

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

657

0.85

0.56

1.5

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.43

0.56

1.8

1.6

ug/l

24.7

104.6

0.47

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.51

0.56

2.6

6.9

74.5

72.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

110

983

1.12

0.55

1.1

u/ml

7.0

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.58

0.54

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.54

0.53

4.8

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.62

0.52

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.50

0.51

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

444

1.17

0.50

2.1

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

127

1.34

0.49

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

540

0.85

0.49

1.2

1.6

e6/l

13.2

26.8

0.54

425

(4034850)

879

1.12

0.48

15.3

10.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2588

26126

0.96

0.48

5.3

5.1

mmol/l

2.6

2.7

12.18

2336

23685

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

0.63

0.48

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

113

1244

0.91

0.47

1.7

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

292

1.20

0.45

1.1

u/ml

1.6

4.1

1.06

145

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.37

0.43

1.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

442

1.16

0.43

1.2

u/l

68.8

35.8

0.65

378

(3024263) Appearance of Synovial fluid

157

1.28

0.43

1.6

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

104

1.35

0.43

1.1

1.2

g/l

—

0.3

—

(3028300) Cannabinoids [Presence] in Urine

480

1.15

0.43

2.1

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.56

0.42

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.56

0.42

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.40

0.42

1.1

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.40

0.42

1.1

—

(3027944) Amphetamines [Presence] in Urine

472

1.15

0.41

2.2

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.36

0.41

2.4

2.8

umol/l

26.9

29.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

541

0.87

0.41

1.3

1.7

e6/l

157.6

1113.5

2.78

442

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

44.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.40

0.0

1.0

—

129.3

—

(3006653) Thiamine [Moles/volume] in Blood

123

1.30

0.40

1.3

1.2

nmol/l

133.2

142.7

0.34

123

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

4.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.40

0.0

1.0

—

157.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

278

1.19

0.40

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.39

0.0

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

124

1.29

0.38

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

160

1.25

0.38

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.38

0.38

1.3

2.3

ug/l

1.1

1.6

0.40

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

476

1.14

0.38

2.1

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

252

1.19

0.37

1.2

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

467

1.14

0.37

1.3

1.4

u/l

11.7

10.4

0.30

368

(21494890) Protein electrophoresis panel - 24 hour Urine

290

1.17

0.36

1.7

1.9

—

(3027008) Opiates [Presence] in Urine

479

1.13

0.35

2.0

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

122

0.74

0.35

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.36

0.34

1.0

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

154

1642

0.93

0.34

2.0

2.2

nmol/l

12.4

0.01

136

1433

(3025130) Human papilloma virus identified in Specimen

210

0.81

0.33

1.5

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

371

3569

1.04

0.33

13.9

7.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2412

23928

1.03

0.30

5.1

4.8

mu/l

2.0

2.1

0.45

2195

21536

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

381

1.13

0.30

1.8

2.1

mg/l

28.3

24.4

—

(3023419) Bacteria identified in Sputum by Culture

381

1.13

0.30

2.1

2.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

268

1.16

0.30

1.4

1.3

e6/l

11876.7

59398.0

0.99

185

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

1.18

0.28

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

669

0.91

0.28

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

1.21

0.27

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

1.21

0.27

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

161

0.81

0.27

3.2

1.9

—

(3023410) Appearance of Cerebral spinal fluid

247

0.85

0.27

1.3

2.0

—

(3020650) Glucose [Presence] in Urine

1.21

0.26

2.1

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2567

25508

1.03

0.26

5.1

4.7

mmol/l

6.3

6.0

16.04

2324

22869

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

178

1.18

0.26

1.3

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2534

25495

0.97

0.26

4.9

4.5

mmol/l

4.5

4.6

10.79

2307

23226

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.67

0.25

1.0

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

378

1.11

0.24

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

715

1.08

0.24

1.5

1.4

—

(3048879) Bone marrow aspiration report

1.17

0.24

1.3

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.28

0.24

1.1

1.2

g/l

0.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.73

0.24

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

284

1.13

0.23

1.1

u/ml

0.5

1.7

1.14

125

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

125

0.80

0.23

1.4

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

181

1.16

0.22

1.0

1.3

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

14.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.21

0.0

1.4

—

1.2

—

(3008898) HLA-B27 [Presence]

662

1.07

0.21

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.16

0.21

1.2

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

11.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

712

1.07

0.20

1.7

—

(4146454)

302

0.89

0.19

2.4

2.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

218

0.87

0.19

1.3

1.5

—

(4094501)

714

0.94

0.18

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

242

1.12

0.18

1.4

1.5

—

(4024509)

310

0.90

0.17

2.0

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

0.84

0.17

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.11

0.17

2.4

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.17

12.6

7.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

660

1.06

0.17

1.7

1.6

e6/l

13699.9

13641.1

0.01

469

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

173

0.87

0.16

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

173

0.87

0.16

1.3

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.16

0.16

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.16

0.16

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.16

0.16

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.14

0.16

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

453

0.93

0.16

1.8

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.13

0.16

1.1

1.2

116.5

109.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.78

0.15

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.08

0.14

1.3

1.2

—

(21494434) Karyotype in Bone marrow

256

1.09

0.14

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

256

1.09

0.14

1.2

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

208

1.11

0.14

1.4

u/l

26.7

31.4

0.28

169

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

335

1.08

0.13

1.1

u/ml

1.5

2.3

0.42

143

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

161

1.12

0.13

1.2

1.3

u/ml

6.2

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

306

1.08

0.12

1.5

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

104

1.15

0.12

1.2

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

191

1.10

0.11

1.0

1.3

mmol/l

2.3

2.1

0.40

181

(3019832) Treponema pallidum Ab [Presence] in Serum

121

1172

1.03

0.11

1.6

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

124

1.13

0.11

1.3

1.4

—

1.4

—

(44813793)

153

1.11

0.11

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

182

1.10

0.11

1.7

2.1

ug/l

1.9

2.2

0.22

150

(3047352) Trisomy 18 risk [Likelihood] in Fetus

167

0.90

0.10

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

166

0.90

0.09

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

203

1.08

0.09

1.0

1.1

u/ml

8.4

4.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

145

0.90

0.09

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.11

0.09

1.3

2.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

206

0.92

0.08

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

206

0.92

0.08

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.07

0.08

14.2

7.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

107

1.12

0.08

3.6

5.8

—

61.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.82

0.08

1.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.82

0.08

1.2

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.08

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

205

0.93

0.08

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

205

0.93

0.08

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.03

0.07

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.03

0.07

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.03

0.07

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.03

0.07

1.0

—

(3044941) Cell count panel - Synovial fluid

429

0.96

0.07

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

313

1.05

0.07

2.2

1.5

66.5

61.4

0.31

200

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.81

0.07

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.81

0.07

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.03

0.07

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

196

1.07

0.07

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.87

0.06

1.0

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

508

0.96

0.06

1.2

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

250

2529

0.99

0.05

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

696

7001

0.99

0.05

1.8

1.6

mmol/l

1.5

1.3

2.20

579

5850

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

208

1.06

0.05

1.0

1.5

nmol/l

0.3

0.26

156

(3047189) Immunofixation for 24 hour Urine

130

0.92

0.04

1.9

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

288

1.04

0.04

1.0

1.1

u/ml

2.9

2.8

0.02

109

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.10

0.04

1.3

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

159

0.94

0.03

22.1

13.5

—

(40765096) Chromosome analysis panel by Banding

1.09

0.03

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

219

0.96

0.03

1.0

1.1

u/ml

2.7

3.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

388

0.98

0.01

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2439

24380

1.00

0.00

4.4

4.0

mmol/l

1.3

4.44

2189

21848

(3021387) Prolactin [Units/volume] in Serum or Plasma

534

1.01

0.00

1.6

mu/l

311.7

306.6

0.04

492

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

0.96

0.00

1.3

1.7

—

(3015183) Erythrocyte sedimentation rate

1.02

0.00

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

174

0.98

0.00

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

151

0.99

0.00

1.5

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

183

0.98

0.00

1.1

u/ml

0.3

0.4

—

(3021788) Differential panel - Synovial fluid

476

1.01

0.00

2.0

1.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.89

0.00

2.2

1.8

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.6

—

7.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.86

0.00

1.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.7

—

1.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.89

0.00

1.0

1.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.9

—

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_BILIAOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_BILIAOTH	2.99 [2.63, 3.4]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.068

During the follow-up period (1.1.1998 — 31.12.2019), 3777 out of 8014 females with K11_BILIAOTH died.

Males

Parameter	HR [95% CI]	p-value
K11_BILIAOTH	3.849 [3.24, 4.57]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 3298 out of 6178 males with K11_BILIAOTH died.

Mortality risk

Mortality risk for people of age

years, who have K11_BILIAOTH.

N-year risk	Females	Males
1	0.218%	0.871%
5	1.37%	4.964%
10	3.625%	11.839%
15	7.078%	21.351%
20	12.539%	34.164%

Relationships between endpoints

↥

Index endpoint: K11_BILIAOTH – Other diseases of biliary tract

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of biliary tract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints